Article
The use of monoclonal antibodies to treat Castleman's disease.
Immunotherapy - 1 Jan 2014
Robey Rebecca C, Mletzko Salvinia, Colley Charlotte, Balachandran Kirsty, Bower Mark
Abstract excerpt
Multicentric Castleman's disease (MCD) is a rare lymphoproliferative disorder presenting with heterogeneous clinical features and with a complex etiology. MCD incidence is increased in people living with HIV/AIDS when it is causally associated with Kaposi's sarcoma-associated herpes virus (KSHV). HIV-seronegative individuals present with either idiopathic or KSHV-associated MCD. Central to MCD pathology is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
